Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/scientificamerican0904-108 | DOI Listing |
Europace
January 2025
Texas Cardiac Arrhythmia Research Foundation, Austin, TX, USA.
Background And Aims: Studies have shown correlations between early recurrence (ER) and late recurrence (LR) of atrial arrhythmia after ablation with thermal technologies. This admIRE trial (NCT05293639) subanalysis aims to analyze ER versus LR in patients with paroxysmal atrial fibrillation (PAF) undergoing pulsed field ablation (PFA).
Methods: Patients with symptomatic paroxysmal atrial fibrillation and ≥1 transtelephonic monitoring transmission during the blanking period were included (n=169).
Hepatol Commun
January 2025
Research and Development, Sanofi, Cambridge, Massachusetts, USA.
Background: Acid sphingomyelinase deficiency (ASMD) and Gaucher disease type 1 (GD1) are rare inherited sphingolipid disorders with multisystemic manifestations, including liver disease and dyslipidemia. Despite effective treatments, insufficient disease awareness frequently results in diagnostic delays during which irreversible complications occur. We delineated the shared and distinctive features of hepatic, splenic, and lipoprotein phenotypes in ASMD and GD1.
View Article and Find Full Text PDFEntropy (Basel)
November 2024
Departamento de Física, Universidad de Cantabria, 39005 Santander, Spain.
The Einstein equation in a semiclassical approximation is applied to a spherical region of the universe, with the stress-energy tensor consisting of the mass density and pressure of the ΛCDM cosmological model plus an additional contribution due to the quantum vacuum. Expanding the equation in powers of Newton constant G, the vacuum contributes to second order. The result is that at least a part of the acceleration in the expansion of the universe may be due to the quantum vacuum fluctuations.
View Article and Find Full Text PDFJAMA Netw Open
December 2024
Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Importance: Fostamatinib, a spleen tyrosine kinase inhibitor, has been reported to improve outcomes of COVID-19.
Objective: To evaluate the efficacy and safety of fostamatinib in adults hospitalized with COVID-19 and hypoxemia.
Design, Setting, And Participants: This multicenter, phase 3, placebo-controlled, double-blinded randomized clinical trial was conducted at 41 US sites and 21 international sites between November 17, 2021, and September 27, 2023; the last follow-up visit was December 31, 2023.
Eur Child Adolesc Psychiatry
December 2024
Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!